Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Neuroinflammation, involving glial cells and peripheral immune cells, is a key factor in amyotrophic lateral sclerosis (ALS) pathogenesis.
• Motor neuron injury in ALS triggers inflammatory responses that contribute to disease progression.
• The balance between anti-inflammatory and pro-inflammatory factors influences ALS progression and patient survival.

Purpose of the Study:

• To review the mechanisms of neuroinflammation in ALS.
• To explore the role of regulatory T lymphocytes (Tregs) in ALS.
• To discuss potential therapeutic strategies targeting neuroinflammation and Tregs in ALS.

Main Methods:

• Review of existing literature on neuroinflammation and ALS.
• Analysis of studies involving transgenic ALS mouse models.
• Examination of clinical trial data for Treg-based therapies in ALS patients.

Main Results:

• Treg cells are reduced and dysfunctional in ALS patients, correlating with disease severity.
• Enhancing Treg numbers and function in mouse models delays disease progression and improves survival.
• Ex vivo expansion of Tregs from ALS patients restores their function.
• A Phase 1 human trial demonstrated the safety and efficacy of autologous Treg infusions in ALS patients.

Conclusions:

• Neuroinflammation plays a critical role in the pathogenesis of ALS.
• Restoring Treg function represents a promising therapeutic strategy for ALS.
• Targeting the immune system, particularly Tregs, offers a potential avenue for slowing ALS progression.